TDQ-Cl ameliorates hepatic fibrosis-associated inflammation and intestinal injury through regulating RXRα-STAT3 signaling
- DOI
- 10.1016/j.intimp.2026.117627
- Published
- 2026-12
- Container
- International Immunopharmacology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117627,
title = {TDQ-Cl ameliorates hepatic fibrosis-associated inflammation and intestinal injury through regulating RXRα-STAT3 signaling},
author = {Sai-Hu Liu and Yu-Nuo Wu and Mei-Yan Xuan and Na-Yan Jin and Shi-Yu Jia and Li-Hua Lian and Ji-Xing Nan and Zhen-Yu Cui and Yan-Ling Wu},
year = {2026},
journal = {International Immunopharmacology},
doi = {10.1016/j.intimp.2026.117627},
url = {https://doi.org/10.1016/j.intimp.2026.117627}
}RIS
TY - JOUR TI - TDQ-Cl ameliorates hepatic fibrosis-associated inflammation and intestinal injury through regulating RXRα-STAT3 signaling AU - Sai-Hu Liu AU - Yu-Nuo Wu AU - Mei-Yan Xuan AU - Na-Yan Jin AU - Shi-Yu Jia AU - Li-Hua Lian AU - Ji-Xing Nan AU - Zhen-Yu Cui AU - Yan-Ling Wu PY - 2026 JO - International Immunopharmacology DO - 10.1016/j.intimp.2026.117627 UR - https://doi.org/10.1016/j.intimp.2026.117627 ER -
APA
Liu, S., Wu, Y., Xuan, M., Jin, N., Jia, S., Lian, L., Nan, J., Cui, Z., & Wu, Y. (2026). TDQ-Cl ameliorates hepatic fibrosis-associated inflammation and intestinal injury through regulating RXRα-STAT3 signaling. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117627
Source records
- crossref · retrieved 2026-11-07T01:57:06.712Z